Pediatric renal transplantation with mycophenolate mofetil immunosuppression in a single center from Mexico

Pediatric Transplantation

Volumn 11, Issue 2, 2007, Pages 134-138

  Martinez Mier, Gustavo ^a,b,c   Mendez Lopez, Marco T ^a   Budar Fernandez, Luis F ^a   Estrada Oros, Jorge ^a   Franco Abaroa, Regino ^a   George Micelli, Esteban ^a   Rios Martinez, Luis ^a   Calzada Grijalva, Jose Francisco ^a   Gonzalez Velazquez, Felipe ^a  

^a IMSS Adolfo Ruiz Cortines National Medical Center   (Mexico)

^b Universidad Cristobal Colon   (Mexico)

^c NONE   (Mexico)

Author keywords

Immunosuppression; Kidney transplantation; Mycophenolate mofetil; Pediatric

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; BRAIN INFECTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEXICO; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; SCHOOL CHILD; THRUSH; TIME SERIES ANALYSIS; URETHRA STENOSIS; URINARY TRACT INFECTION; VIREMIA;

ADOLESCENT; CHILD; CREATININE; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEXICO; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 33846585091     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00637.x     Document Type: Article

References (20)

1. Excerpts from the 1993 USRDS annual data report. Am J Kidney Dis 1993: 22(4 Suppl. 2): 1-118.
2. U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
3. MILLER LC, BOCK GH, LUM CT, NAJARIAN JS, MAUER SM. Transplantation of adult kidney into the very small child: Long-term outcome. J Pediatr 1982: 100: 675-680.
4. SARWAL MM, CECKA JM, MILLAN MT, SALVATIERRA O Jr. Adult-size kidneys without acute tubular necrosis provides exceedingly superior long-term graft outcomes for infants and small children: A singe center and UNOS analysis. United Network for Organ Sharing. Transplantation 2000: 70: 1728-1736.
5. COLOMBANI PM, DUNN SP, HARMON WE, MAGEE JC, MCDIARMID SV, SPRAY TL. Pediatric transplantation. Am J Transplant 2003: 3(Suppl. 4): 53-63.
6. AIKAWA A, ARAI K, KAWAMURA T, et al. First living related kidney transplantation results in excellent outcomes for small children. Transplant Proc 2005: 37: 2947-2950.
7. DOBBELS F, VAN DAMME-LOMBAERT R, VANHAECKE J, DE GEESTS S. Growing pains: Non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005: 9: 381-390.
8. ALLLISON AC, EUGUI EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 1993: 14: 353-380.
9. ALLLISON AC, EUGUI EM. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 1994: 26: 3205-3210.
10. ETTENGER R, COHEN A, NAST C, MOULTON L, MARIK J, GALES B. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc 1997: 29: 340-341.
11. BENFIELD MR, SYMONS JM, BYNON S, et al. Mycophenolate mofetil in pediatric renal transplantation. Pediatr Transplant 1999: 3: 33-37.
12. HOECKER B, WEBER LT, BUNCHMAN T, RASHFORD M, TONSHOFF B, Tricontinental MMF Suspension study group. Mycophenolate mofetil suspension in pediatric renal transplantation: Three-year data from the tricontinental trial. Am J Transplant 2005: 5 (Suppl. 11): 494.
13. STASKEWITZ A, KIRSTE G, TONSHOFF B, et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: Results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation 2001: 71: 638-644.
14. JUNGRAITHMAYR T, STASKEWITZ A, KIRSTE G, et al. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: Results after three years. Transplantation 2003: 75: 454-461.
15. FERRARIS JR, GHEZZI LF, VALLEJO G, PIANTANIDA JJ, ARAUJO JL, SOJO ET. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil. Pediatr Transplant 2005: 9: 178-182.
16. OTUKESH H, SHARIFIAN M, BASIRI A, et al. Mycophenolate mofetil in pediatric renal transplantation. Transplant Proc 2005: 37: 3012-3015.
17. SCHWARTZ GJ, GAUTHIER B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985: 106: 522-526.
18. RACUSEN LC, COLVIN RB, SOLEZ K, et al. Antibody-mediated rejection criteria - and addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003: 3: 708-714.
19. FOSTER BJ, LEONARD MB. Measuring nutritional status in children with chronic kidney disease. Am J Clin Nut 2004: 80: 801-814.
20. BUNCHMAN T, NAVARRO M, BROYER M, et al. The use of mycophenolate mofetil suspension in pediatric renal allograft recipients. Pediatr Nephrol 2001: 16: 978-984.